Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,809,480
  • Shares Outstanding, K 289,006
  • Annual Sales, $ 19,372 M
  • Annual Income, $ 1,484 M
  • 60-Month Beta 0.42
  • Price/Sales 3.46
  • Price/Cash Flow 11.44
  • Price/Book 2.58
Trade BDX with:

Options Overview Details

View History
  • Implied Volatility 18.23% ( -0.27%)
  • Historical Volatility 13.86%
  • IV Percentile 34%
  • IV Rank 20.85%
  • IV High 28.78% on 08/05/24
  • IV Low 15.45% on 08/30/24
  • Put/Call Vol Ratio 2.68
  • Today's Volume 2,979
  • Volume Avg (30-Day) 603
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 20,120
  • Open Int (30-Day) 18,477

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 3.76
  • Number of Estimates 9
  • High Estimate 3.83
  • Low Estimate 3.74
  • Prior Year 3.42
  • Growth Rate Est. (year over year) +9.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
229.31 +1.83%
on 09/11/24
244.98 -4.69%
on 09/03/24
-1.24 (-0.53%)
since 08/20/24
3-Month
218.75 +6.74%
on 07/10/24
244.98 -4.69%
on 09/03/24
-4.90 (-2.06%)
since 06/20/24
52-Week
218.75 +6.74%
on 07/10/24
269.52 -13.36%
on 10/10/23
-33.63 (-12.59%)
since 09/20/23

Most Recent Stories

More News
3 Dividend Aristocrats that Could Double The Dividend

Discover three Dividend Aristocrats poised for dividend growth and long-term returns.

SPGI : 523.67 (-0.10%)
BDX : 233.50 (-0.48%)
WMT : 79.06 (+1.31%)
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including...

ABT : 113.70 (-0.39%)
BSX : 83.92 (+0.25%)
BDX : 233.50 (-0.48%)
MDT : 89.34 (-0.15%)
Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

BDX : 233.50 (-0.48%)
$NASX : 17,948.32 (-0.36%)
BAX : 38.49 (-0.70%)
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?

Shares of Hologic HOLX are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months,...

BDX : 233.50 (-0.48%)
HOLX : 81.39 (-1.23%)
QGEN : 44.90 (-1.51%)
BD Stock Falls After Acquisition of Edwards' Critical Care Group

Becton, Dickinson, and Company BDX, popularly known as BD, completed its acquisition of Edwards Lifesciences Corporation EW Critical Care product group, renaming it BD Advanced Patient Monitoring.BD had...

BDX : 233.50 (-0.48%)
DGX : 152.99 (-1.37%)
UHS : 238.02 (+0.10%)
EW : 66.83 (-0.64%)
Stryker Stock: Is SYK Outperforming the Healthcare Sector?

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

SYK : 364.81 (-0.07%)
XLV : 155.28 (-0.41%)
BDX : 233.50 (-0.48%)
Are Wall Street Analysts Predicting Becton, Dickinson, and Company Stock Will Climb or Sink?

While Becton, Dickinson, and Company has failed to surpass the broader market over the past year, Wall Street analysts are highly bullish on the stock’s prospects.

BDX : 233.50 (-0.48%)
$SPX : 5,702.55 (-0.19%)
IHI : 59.12 (-0.45%)
RJF : 124.31 (+0.16%)
Becton Dickinson: Fiscal Q3 Earnings Snapshot

Becton Dickinson: Fiscal Q3 Earnings Snapshot

BDX : 233.50 (-0.48%)
What to Expect From Becton, Dickinson and Company’s Next Quarterly Earnings Report

Becton, Dickinson and Company is all set to release its fiscal third-quarter earnings next month, and analysts expect a double-digit profit increase.

BDX : 233.50 (-0.48%)
$SPX : 5,702.55 (-0.19%)
IHI : 59.12 (-0.45%)
3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

ZTS : 192.64 (-0.31%)
$SPX : 5,702.55 (-0.19%)
XLV : 155.28 (-0.41%)
BDX : 233.50 (-0.48%)
DXCM : 70.43 (-2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 237.28
2nd Resistance Point 235.73
1st Resistance Point 234.62
Last Price 233.50
1st Support Level 231.96
2nd Support Level 230.41
3rd Support Level 229.30

See More

52-Week High 269.52
Fibonacci 61.8% 250.13
Fibonacci 50% 244.13
Fibonacci 38.2% 238.14
Last Price 233.50
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar